OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Molecular profiling and clinical implications of patients with acute myeloid leukemia and extramedullary manifestations
Jan‐Niklas Eckardt, Friedrich Stölzel, Désirée Kunadt, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

CD36 Drives Metastasis and Relapse in Acute Myeloid Leukemia
Thomas Farge, Jean Nakhle, Damien Lagarde, et al.
Cancer Research (2023) Vol. 83, Iss. 17, pp. 2824-2838
Open Access | Times Cited: 31

C1Q labels a highly aggressive macrophage-like leukemia population indicating extramedullary infiltration and relapse
Lixue Yang, Cheng-Tao Zhang, Meng‐Ying Yang, et al.
Blood (2022) Vol. 141, Iss. 7, pp. 766-786
Open Access | Times Cited: 25

Myeloid sarcoma: more and less than a distinct entity
Giuseppe Gaetano Loscocco, Alessandro M. Vannucchi
Annals of Hematology (2023) Vol. 102, Iss. 8, pp. 1973-1984
Open Access | Times Cited: 16

The Role of CXCR1, CXCR2, CXCR3, CXCR5, and CXCR6 Ligands in Molecular Cancer Processes and Clinical Aspects of Acute Myeloid Leukemia (AML)
Jan Korbecki, Patrycja Kupnicka, Katarzyna Barczak, et al.
Cancers (2023) Vol. 15, Iss. 18, pp. 4555-4555
Open Access | Times Cited: 12

Clinical and molecular characteristics of extramedullary acute myeloid leukemias
Tariq Kewan, Waled Bahaj, Carmelo Gurnari, et al.
Leukemia (2024) Vol. 38, Iss. 9, pp. 2032-2036
Open Access | Times Cited: 4

Efficacy and safety of CAR-T therapy targeting CLL1 in patients with extramedullary diseases of acute myeloid leukemia
Yifan Zhao, Xue Bai, Shujing Guo, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4

Diagnostic Approaches in Myeloid Sarcoma
Elżbieta Patkowska, Agnieszka Krzywdzińska, Iwona Solarska, et al.
Current Issues in Molecular Biology (2025) Vol. 47, Iss. 2, pp. 111-111
Open Access

Pediatric Myeloid Sarcoma, More than Just a Chloroma: A Review of Clinical Presentations, Significance, and Biology
Kristin E. Zorn, Ashley M. Cunningham, Alison E. Meyer, et al.
Cancers (2023) Vol. 15, Iss. 5, pp. 1443-1443
Open Access | Times Cited: 9

Expression profiling of extramedullary acute myeloid leukemia suggests involvement of epithelial–mesenchymal transition pathways
Tiziana Ottone, Giorgia Silvestrini, Rocco Piazza, et al.
Leukemia (2023) Vol. 37, Iss. 12, pp. 2383-2394
Closed Access | Times Cited: 9

Genetic alterations in myeloid sarcoma among acute myeloid leukemia patients: insights from 37 cohort studies and a meta-analysis
Suvijak Untaaveesup, Sasinipa Trithiphen, Kamolchanok Kulchutisin, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 3

MNDA, a PYHIN factor involved in transcriptional regulation and apoptosis control in leukocytes
Stefania Bottardi, Taylorjade Layne, Ailyn C. Ramòn, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3

Myeloid sarcoma: An overview
Maximiliano Ramia de, Weina Chen
Seminars in Diagnostic Pathology (2023) Vol. 40, Iss. 3, pp. 129-139
Closed Access | Times Cited: 7

Iron overload promotes the progression of MLL-AF9 induced acute myeloid leukemia by upregulation of FOS
Feifei Yang, Xiaoxi Cui, Hao Wang, et al.
Cancer Letters (2024), pp. 216652-216652
Closed Access | Times Cited: 2

The Role of Epithelial-to-Mesenchymal Transition Transcription Factors (EMT-TFs) in Acute Myeloid Leukemia Progression
Diego Cuevas, Roberto Amigo, Adolfo Agurto, et al.
Biomedicines (2024) Vol. 12, Iss. 8, pp. 1915-1915
Open Access | Times Cited: 2

Myeloid sarcoma with NPM1 mutation may be clinically and genetically distinct from AML with NPM1 mutation: a study from the Bone Marrow Pathology Group
Maximiliano Ramia de, Leo P. Wu, Christian Hirt, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2023) Vol. 64, Iss. 5, pp. 972-980
Closed Access | Times Cited: 5

Systematic review and meta-analysis evaluating clinical outcomes in adult acute myeloid leukemia patients with central nervous system involvement
Hannah Goulart, Dahniel Sastow, Erin Moshier, et al.
Leukemia Research (2024) Vol. 137, pp. 107452-107452
Closed Access | Times Cited: 1

Organomegalies as a predictive indicator of leukemia cutis in patients with acute myeloid leukemia
Chanakarn Kanitthamniyom, Chalothorn Wannaphut, Penvadee Pattanaprichakul, et al.
PLoS ONE (2024) Vol. 19, Iss. 2, pp. e0297805-e0297805
Open Access | Times Cited: 1

Diagnostic approach to leukemia cutis : A differential diagnostic step-by-step algorithm
Alex Jenei, Alexandar Tzankov
American Journal of Clinical Pathology (2024)
Open Access | Times Cited: 1

Gene Mutations and Targeted Therapies of Myeloid Sarcoma
Leihua Fu, Zhijian Zhang, Zhe Chen, et al.
Current Treatment Options in Oncology (2023) Vol. 24, Iss. 4, pp. 338-352
Closed Access | Times Cited: 3

MicroRNA-143 acts as a tumor suppressor through Musashi-2/DLL1/Notch1 and Musashi-2/Snail1/MMPs axes in acute myeloid leukemia
Fanfan Li, Yixiang Han, Rongrong Chen, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 2

Page 1 - Next Page

Scroll to top